Literature DB >> 27379449

The evolving frontier of diabetes therapy: The renaissance of glycemology.

Antonio Ceriello1, Stefano Genovese2, Emanuele Bosi3.   

Abstract

It was previously proposed that diabetes could be a "cardiovascular disease". This concept was based on evidence showing that controlling hypertension and dyslipidemia could be more effective than controlling hyperglycemia. At that time it was concluded that the real need to focus on reaching optimal glycemic control had lost its appeal. However, the concept of glycemic control was strictly correlated to levels of glycated hemoglobin (HbA1c), the integrated measure of mean glycemia over the previous 2-3months, while recent evidence suggests that the concept of hyperglycemia has profoundly changed, and it is more appropriate to speak of different kinds or aspects of hyperglycemia. A modern, updated approach to glycemic control in people with diabetes, in fact, must focus not only on reaching and maintaining optimal HbA1c levels as soon as possible, but to obtain this result by reducing postprandial hyperglycemia and glycemic variability, while avoiding hypoglycemia.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Cardiovascular disease; Glucose variability; Glycemology; HbA1c; Hypoglycemia; Postprandial hyperglycemia

Mesh:

Substances:

Year:  2016        PMID: 27379449     DOI: 10.1016/j.diabres.2016.04.036

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  1 in total

1.  HbA1c variability and long-term glycemic control are linked to peripheral neuropathy in patients with type 1 diabetes.

Authors:  M V Pinto; L C G F Rosa; L F Pinto; J R Dantas; G F Salles; L Zajdenverg; M Rodacki; M A Lima
Journal:  Diabetol Metab Syndr       Date:  2020-10-06       Impact factor: 3.320

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.